Infection Control Market Share, Size, Trends, Industry Analysis Report, By Type; End-use; By Region; Segment Forecast, 2023 - 2032
The global infection control market size is expected to reach USD 400.81 billion by 2032, according to a new study by Polaris Market Research. The report “Infection Control Market Share, Size, Trends, Industry Analysis Report, By Type (Equipment, Services, Consumables, Others); End-use; By Region; Segment Forecast, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The rise in surgical procedures that require rigorous infection control is the main factor driving the market. The positive therapeutic outcomes produced using infection control are regarded to be the cause of the high preference. The COVID-19 pandemic has positively impacted market growth due to the rise in demand for sterilization and disinfection in hospitals and clinics, pharmaceutical and medical device sectors.
According to the WHO's practical advice on the prevention of HAI, the extra amount of time spent in the hospital due to surgical infections was estimated to be around 8 days. These prolonged stays are anticipated to result in a large increase in hospital costs, which heightens the clinical urgency for implementing infection prevention measures. It is anticipated that prolonged hospital stays are not cost-effective for hospitals and healthcare payers as a result of the excessive use of resources to treat the acquired infection.
The market for infection control on a global scale is competitive and only somewhat fragmented. Industry participants are focusing on new product releases, product developments, and global growth in order to improve their market share. Some of the key players in the market include Fortive (Advanced Sterilization Products), 3M Company, Getinge AB, Steris PLC, and Cantel Medical Corporation.
Diseases include pneumonia, infections of the bloodstream, urinary tract, surgical site, and MRSA are the main causes of hospital-acquired infections. Other prominent hospital-acquired infections (HAI) include catheter-related bloodstreams, catheter-associated urinary tract infections, and pneumonia related to ventilators. HAI is one of the major problems that hinders patient recovery and significantly affects death rates globally.
Infection Control Market Report Highlights
Hospitals held the biggest revenue share in 2022 and are projected to grow at the fastest rate (CAGR) throughout the course of the forecast period. The significant portion of infections is primarily due to the high risk of contracting diseases on hospital property through respiratory or bloodborne pathogen transmission.
North America led the industry share in 2022. The increased market share that this sector has managed to capture is regarded to be a result of a consistent number of strategic partnerships taken up by major market participants to increase their product offering and infection control capabilities. The greater efforts made by existing companies to establish themselves throughout this region are also to blame for North America's dominant market share.
3M Corporation, Belimed AG, Halyard Health, Getinge Group, Matachana Group, and others are some of the leading companies competing in the international market.
Polaris Market Research has segmented the Infection Control Market report based on type, end-use, and region:
Infection Control Market, Type (Revenue - USD Billion, 2019 - 2032)
Equipment
Services
Consumables
Others
Infection Control Market, End Use (Revenue - USD Billion, 2019 - 2032)
Hospital
Medical Device Company
Pharmaceutical Laboratories
Infection Control Market, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa